AN2 Therapeutics, Inc.(ANTX)

Biotechnology · Menlo Park, CA

$5.07-0.54 (-9.63%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Compare

Interest Coverage Ratio: N/A

Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.

The interest coverage ratio is N/A as of Tuesday, October 6, 2026.

Interest Expense|Total Debt|Debt/Equity|Operating Margin|All Metrics

ANTX Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

N/A

ANTX Competitors' Interest Coverage Ratio

ANTX

AN2 Therapeutics, Inc.

Current

Market Cap

$182.60M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTN

Canton Strategic Holdings Inc

vs ANTX

Market Cap

$180.47M

Interest Coverage Ratio

-709.33x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CMPX

Compass Therapeutics, Inc.

vs ANTX

Market Cap

$179.75M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORMP

Oramed Pharmaceuticals Inc.

vs ANTX

Market Cap

$179.26M

Interest Coverage Ratio

N/A

TTM Avg

14.48x

3Y Avg

14.48x

5Y Avg

14.48x

ELDN

Eledon Pharmaceuticals, Inc.

vs ANTX

Market Cap

$189.11M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZNTL

Zentalis Pharmaceuticals, Inc.

vs ANTX

Market Cap

$190.07M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

YARW

Yarrow Bioscience Inc

vs ANTX

Market Cap

$174.27M

Interest Coverage Ratio

N/A

TTM Avg

57.53x

3Y Avg

57.53x

5Y Avg

57.53x

PRQR

ProQR Therapeutics N.V.

vs ANTX

Market Cap

$173.76M

Interest Coverage Ratio

-48.66x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RXST

RxSight, Inc.

vs ANTX

Market Cap

$192.49M

Interest Coverage Ratio

-1204.75x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ORGO

Organogenesis Holdings Inc.

vs ANTX

Market Cap

$172.42M

Interest Coverage Ratio

N/A

TTM Avg

8.41x

3Y Avg

7.29x

5Y Avg

7.29x

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
AN2 Therapeutics, Inc. (ANTX)	$182.60M	N/A	N/A	N/A	N/A
Canton Strategic Holdings Inc (CNTN)vs ›	$180.47M	-709.33x	N/A	N/A	N/A
Compass Therapeutics, Inc. (CMPX)vs ›	$179.75M	N/A	N/A	N/A	N/A
Oramed Pharmaceuticals Inc. (ORMP)vs ›	$179.26M	N/A	14.48x	14.48x	14.48x
Eledon Pharmaceuticals, Inc. (ELDN)vs ›	$189.11M	N/A	N/A	N/A	N/A
Zentalis Pharmaceuticals, Inc. (ZNTL)vs ›	$190.07M	N/A	N/A	N/A	N/A
Yarrow Bioscience Inc (YARW)vs ›	$174.27M	N/A	57.53x	57.53x	57.53x
ProQR Therapeutics N.V. (PRQR)vs ›	$173.76M	-48.66x	N/A	N/A	N/A
RxSight, Inc. (RXST)vs ›	$192.49M	-1204.75x	N/A	N/A	N/A
Organogenesis Holdings Inc. (ORGO)vs ›	$172.42M	N/A	8.41x	7.29x	7.29x

Financial Health Indicators

Interest Coverage

N/A

Debt/Equity

0.00

Current Ratio

14.32

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

< 1.5x: EBIT is less than 1.5 times interest expense
1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
3x - 5x: EBIT is between 3 and 5 times interest expense
> 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio: N/A

ANTX Interest Coverage Ratio Metrics

ANTX Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Related Metrics